プロの翻訳者、企業、ウェブページから自由に利用できる翻訳レポジトリまで。
fil- ko-orti ta’ labcc pazjent kien meqjus bħala li rrisponda jekk mill-inqas wieħed mill-kriterji li ġejjin kien sodisfat u l-pazjent ma kellux progressjoni: (1) tnaqqis ta’ ≥ 30 % fid-daqs tal-leżjoni [total tal- itwal dijametru (sld - sum of the longest diameter)], mil-linja bażi ta’ leżjonijiet immirati minn radjografija; (2) tnaqqis ta’ ≥ 30 % f’sld mil-linja bażi fid-dimensjoni viżibbli esterna ta’ leżjonijiet immirati; (3) fejqan komplut tal-ulċerazzjoni fil-leżjonijiet immirati kollha.
a patient was considered a responder in the labcc cohort if at least one of the following criteria was met and the patient did not experience progression: (1) ≥ 30 % reduction in lesion size [sum of the longest diameter (sld)], from baseline in target lesions by radiography; (2) ≥ 30 % reduction in sld from baseline in externally visible dimension of target lesions; (3) complete resolution of ulceration in all target lesions.